These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8039432)

  • 21. Renal and stroke protection in hypertensive patients at CV risk.
    Cardiovasc J Afr; 2007; 18(5):337, 340. PubMed ID: 17985036
    [No Abstract]   [Full Text] [Related]  

  • 22. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension in diabetes mellitus. Causes, follow-up and treatment].
    Klaus D
    Med Klin (Munich); 1994 Jun; 89(6):330-8. PubMed ID: 8072457
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.
    Weidmann P; Schneider M; Böhlen L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():39-45. PubMed ID: 8643207
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 26. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
    Rossing P
    Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence-based treatment of hypertension in patients with diabetes mellitus.
    Onuigbo M; Weir MR
    Diabetes Obes Metab; 2003 Jan; 5(1):13-26. PubMed ID: 12542721
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hypertension in patients with adult-onset diabetes].
    Mykkänen L
    Duodecim; 1999; 115(10):1147-53. PubMed ID: 11877854
    [No Abstract]   [Full Text] [Related]  

  • 30. The pre-proteinuric phase of diabetic nephropathy.
    Christensen CK
    Dan Med Bull; 1991 Apr; 38(2):145-59. PubMed ID: 2060322
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of imidazoline receptor agonist moxonidine on the state of microcirculation and renal function in patients with hypertension and diabetes mellitus type 2].
    Trusov VV; Aksenov KV
    Kardiologiia; 2003; 43(9):44-8. PubMed ID: 14682297
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetic nephropathy.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S69-72. PubMed ID: 12017684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Which antihypertensive drugs for diabetic patients? Remembering the organ protective potential!].
    MMW Fortschr Med; 2001 Jul; 143(26-27):54. PubMed ID: 11481919
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.